methyl 3-cyclopropyl-1-methyl-1H-pyrazole-5-carboxylate, 500mg

Polymethylhydrosiloxanes, trimethlysiloxy terminated 15-25cSt, = 99% (GC), 100g

(2E)-3-(2,5-dimethoxyphenyl)-1-(4-ethylphenyl)prop-2-en-1-one, 95.0%, 2g

2-ETHYL2-FLUORO-BUTANOIC ACID, 95.0%, 250mg

4-(Naphthalen-2-yl)aniline, 98%, 1g

1-(5-CHLORO-THIOPHEN-3-YL)ETHANOL, 95.0%, 10g

7-(2,3-Dihydroxypropyl)-1,3-dimethyl-1H-purine-2,6(3H,7H)-dione, 95.0%, 5g

tert-Butyl 1-(isopropylsulfonyl)piperidin-4-ylcarbamate, 95.0%, 1g

METHYL 2-CHLOROQUINAZOLINE-5-CARBOXYLATE, 95.0%, 250mg

3-(Difluoromethoxy)benzonitrile, 95.0%, 1g

Bis(6-methylheptyl) phthalate, 95.0%, 1g

N,N,N',N'-Tetramethyl-S-(1-oxido-2-pyridyl)thiuronhexafluorophosphate, 5g

1-(4-bromopyridin-2-yl)-3-ethylurea, 95%, 500mg